Funding · Commerce & Consumer Brands

Pee Safe raises $32M from OrbiMed

By Startup Enthusiast · 14 January 2026

What they do

Pee Safe makes women's hygiene products like intimate washes and organic cotton tampons

It raised about $32 million in growth capital from healthcare-focused private equity firm OrbiMed

The round includes a secondary sale, giving partial exits to early investors

Pee Safe raised about $32 million (INR 290 crore) in growth capital from OrbiMed, a global healthcare-focused private equity firm.
The round is a mix of primary shares (new money to the company) and secondary shares (existing shareholders selling their shares).
Early investors are making a partial exit through the secondary sale.
Dr Sunny Sharma (Senior Managing Director, OrbiMed Asia) and Sumona Chakraborty (Executive Director) join Pee Safe's board.
The company plans to use the funds to expand offline retail, strengthen brand-led marketing, and accelerate growth on quick commerce and marketplaces.

The femtech market globally was worth $60.2 billion in 2024 and is expected to grow at a CAGR of 16% over the next decade.
OrbiMed manages about $20 billion across public and private investments and has backed Indian companies like Kapiva, Innvolution Healthcare, and Marksans Pharma.
Competitors include Sirona, Sanfe, Nua Women, Plush, Johnson & Johnson, and Procter & Gamble.

Pee Safe is a women's hygiene and wellness brand offering products for toilet hygiene, feminine/intimate hygiene, personal care, grooming, and wellness.
Its product range includes organic cotton tampons, breast pads, panty liners, intimate wash (for men and women), wipes, maternity care, and anti-pollution dust masks.
The company has a presence across 50,000+ offline retail touchpoints in 100+ cities and 23 international markets.
It achieved an annualised net revenue run rate (NRR) of over INR 150 crore.
In FY25, revenue from operations was INR 82 crore, up 46% from INR 56 crore in FY24.
Its loss narrowed to INR 4 crore in FY25, down 69% from INR 13 crore in FY24.

OrbiMed (lead) — Global healthcare-focused private equity firm managing about $20 billion.

Product: s hygiene brand
Customers: Consumers seeking personal hygiene, intimate care, and women's menstrual and hormonal wellness products.
How it makes money: Generates revenue by selling branded personal hygiene, menstrual care, and wellness supplement products through online and offline channels.
What sets it apart: Established category creator in toilet hygiene sprays with multi-category presence across menstrual health and nutraceuticals.